🔬Spotlight on research🔬 Head over to #AMMF’s social media to hear more information from Dr Veronica Porreca. Dr Porreca will be sharing her insights on her AMMF funded #research. ow.ly/Uran50X0Xz4 #CCA #cholangiocarcinoma

🔬Spotlight on research🔬 Head over to #AMMF’s social media to hear more information from Dr Benjamin Dwyer. Dr Dwyer will be sharing their insights on their AMMF funded #research. ow.ly/LlaM50WYT7v #CCA #cholangiocarcinoma

Professor John Bridgewater appeared on the @simplyoncology podcast to raise awareness and provide more information about biliary tract cancers. You can listen to the podcast here: ow.ly/MOKv50WWClL #AMMF #bileductcancer #cholangiocarcinoma #CCA #biliarytractcancer

🔬Spotlight on research🔬 Head over to #AMMF’s social media to hear more information from Professor Shahid Khan & Dr Nitiwat Sirijun. They will both be sharing their insights on their #AMMF funded #research. ow.ly/X1lW50WXnQM #CCA #cholangiocarcinoma

#AMMF will be joined by Dr Christopher Wadsworth, Professor Sheela Jayaramen and CCA patient advocates in the upcoming webinar on the role of stents. Date: 24th September2025 Time: 6:00pm–7:30pm BST Location: us02web.zoom.us/webinar/regi... #bileductcancer #stents #CCA #webinar

#AMMF will be hosting the third session in our patient and carer webinar series: Understanding the role of stents in the management of #cholangiocarcinoma Date: 24th September2025 Time: 6:00pm–7:30pm BST Location: us02web.zoom.us/webinar/regi... #bileductcancer #stents #CCA #webinar

🔬Spotlight on research🔬🔬 Head over to #AMMF’s Facebook page to hear more information from Dr Ed Jarman. Dr Jarman will be sharing his insights on his #AMMF funded #research. ow.ly/PPRP50WTJo8 #CCA #cholangiocarcinoma #bileductcancer

#AMMF will be joined by Dr Christopher Wadsworth, Professor Sheela Jayaramen and CCA patient advocates in the upcoming webinar on the role of stents. Date: 24th September 2025 Time: 6:00pm–7:30pm BST Location: us02web.zoom.us/webinar/regi... #bileductcancer #stents #CCA #webinar

🔬Spotlight on research🔬🔬 Head over to #AMMF’s social media platforms to hear more information from our very own Head of Policy and Research, Paul Howard. Paul will be sharing his insights on AMMF funded #research. ow.ly/zafO50WRa3S #CCA #cholangiocarcinoma

SAVE THE DATE! The next #cca-uk meeting will be held in December 2025 in Nottingham. The focus of the meeting with be the fundamental science underlying #cholangiocarcinoma and is aimed at researchers and clinicians. Further details will be shared in due course. #AMMF #bileductcancer #CCA

On 27 August 2025 #AMMF united with 60 other cancer charities outside the Houses of Parliament tourge the UK Government to deliver a #NationalCancerPlan for England that is ambitious and fully funded. #OneCancerVoice #Cholangiocarcinoma #BileDuctCancer #CCA #RethinkLiverCancer

#AMMF will be hosting the third session in our patient and carer webinar series: Understanding the role of stents in the management of #cholangiocarcinoma Date: 24th September 2025 Time: 6:00pm–7:30pm BST Location: us02web.zoom.us/webinar/regi... #bileductcancer #stents #CCA

🟣SAVE THE DATE🟣 #AMMF is pleased to announce the save the date details of our annual European #Cholangiocarcinoma Conference May 2026. 📅: 13-15 May 2026 📍: Radisson Blu, Stanstead, UK Further information regarding registration will be provided soon. #bileductcancer #CCA

This month, the UK Government launched its #10YearHealthPlan for England. To read about what this could mean for #cholangiocarcinoma patients, visit the following link: ammf.org.uk/2025/07/21/10-…

Write to your MP and support the #RareCancersBill. Call for: More research Rare cancer champions in all UK nations Better incentives for orphan drugs Let’s push for better care, faster diagnoses & more hope. #CancerAwareness #HealthEquity #cholangiocarcinoma #CCA #AMMF

If you or a loved one has a #BiliaryTractCancer, please take part in our new online surveys to share your experiences, preferences and priorities with #AMMF. Patients: forms.gle/dQ5piqPeuTcf... Partners/Family/Caregivers: forms.gle/Pn6Mb3Fs3EfE...

It was good to make the case for the molecular testing we need to help patients with cholangiocarcinoma in Scotland to @jennimintomsp.bsky.social and the Scottish Government. Hopefully this will stimulate a solution. Thanks to @benmacpherson.bsky.social for hosting.

#AMMF was at Holyrood last night! Professor @timkendall.bsky.social highlighted the need for a comprehensive molecular testing programme in Scotland to prevent some #cholangiocarcinoma patients missing out on treatment opportunities. #RethinkLiverCancer #FairerDealFaster

#AMMF’s @ammf-ceo.bsky.social shared data from the Scottish Cancer Registry revealing #CCA rates are higher in Scotland than in England & increased by over 40% from 2001-2018. This highlights the need to #RethinkLiverCancer & get a #FairerDealFaster for CCA patients in Scotland.

#CCA patient Kevin Wemyss spoke bravely about the disparities in molecular profiling in Scotland on STV #AMMF are looking forward to discussing ways to #RethinkLiverCancer with @jennimintomsp.bsky.social at our reception at Holyrood tomorrow. ow.ly/JjJV50W6iUN ow.ly/euOf50W6iUO

Addenbrooke’s Hospital, Cambridge, has announced that it will be the first in the UK to offer #histotripsy for NHS patients with liver tumours. Learn more about the therapy & the announcement on #AMMF’s website. ammf.org.uk/2025/05/30/h... #cholangiocarcinoma #bileductcancer

What is histotripsy? There has been a lot of interest in histotripsy within the #CCA patient community. To help you understand more about this therapy, #AMMF has prepared a new page for our website - ammf.org.uk/2025/05/30/h... #cholangiocarcinoma

Last week, DiCE virtually attended the #AMMF2025, organised by @charityammf.bsky.social. The conference had a variety of expert sessions on progress in personalised medicine, novel research in the #CCA field, & updates on CCA treatment from within the 🇬🇧, 🇪🇺, and 🌎. ➡️ ammf.org.uk/ammf-confere...

That’s a wrap on #AMMF2025! Thank you to everyone – speakers, presenters, attendees, and partners – for three powerful days of insight, science, and connection in #cholangiocarcinoma.

Winner of the Fast Science Award at #AMMF2025: Ghada Nouairia of Karolinska Institutet, Sweden! Her work: Genome-scale DNA methylation profiling of biliary tract cancers. A brilliant contribution to advancing BTC research.

Congratulations to Prof John Bridgewater on winning the Outstanding Poster Award at #AMMF2025! His poster: A Phase 3, randomised study of adjuvant rilvegostomig plus chemotherapy in resected biliary tract cancer: ARTEMIDE-Biliary01

“I’ve been trying to find different treatments for those who can’t avail targeted therapy” – Prof. Padma-Sheela Jayaraman. Her team shows palbociclib + niclosamide work synergistically, reduce CCA cell viability, and shrink tumours in preclinical models. @uniofnottingham.bsky.social #AMMF2025

@euanbrennan.bsky.social @edinburgh-uni.bsky.social explored how 'stretch' signals might shape early iCCA development — affecting gene activity, cell structure, and signalling. #AMMF2025 #Fastscience #cholangiocarcinoma

“Our findings offer valuable insights for identifying key biomarkers, drug and vaccine targets.” Miss Waraporn Taweesin of Khon Kaen University, Thailand shared transcriptomic data from Opisthorchis viverrini across life stages. #AMMF2025 #Fastscience #cholangiocarcinoma

Dr Ghada Nouairia presented research on genome-scale DNA methylation profiling in biliary tract cancers. With support from a new CCA Foundation grant, she’s now moving into validation — watch this space for future results. @ki.se #AMMF2025 #Fastscience

Euan Brennan is exploring bio-mechanical signals during iCCA initiation in a Fast science presentation. Join live on our virtual platform: rb.gy/s6p2aw @euanbrennan.bsky.social @edinburgh-uni.bsky.social #AMMF2025 #Fastscience #cholangiocarcinoma

Our final Session theme of the day will be Fast Science. Join us for bitesize presentations on the latest in CCA. Join on our virtual platform: rb.gy/s6p2aw #AMMF2025 #bileductcancer

Time to grab some food, have a break, and network with fellow attendees. Those at home, can visit our virtual platform for exclusive content and session replays: rb.gy/s6p2aw #AMMF2025 #Networking

Connect with our panellists and ask your questions on the novel therapy areas discussed. Join on our virtual platform: rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma

Our discussion panel highlights why AMMF’s funding is so important—backing early-stage ideas that need a chance to grow: “When you're up against the bigger cancer types... trying to get that pilot data to give you some momentum is really key.” #AMMF2025 #Fairerdealfaster

What role does artificial intelligence play in CCA research? Join Nathalie Feeley @edinburgh-uni.bsky.social now to find out more on our virtual platform: rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma #AIinresearch

“Trying to improve CUPiD” AMMF-funded work by Dr Alicia-Marie Conway is adapting the CUPiD platform—originally developed for cancers of unknown primary—to detect confirmed CCA cases. A promising step toward more accurate, non-invasive diagnosis. @cruk-mi.bsky.social #AMMF2025

Professor Dhanny Gomez will discuss using mini robots with wireless electrical-molecular signalling to tackle #cholangiocarcinoma. Tune in to our virtual platform: rb.gy/s6p2aw @uniofnottingham.bsky.social #AMMF2025 #MedicalResearch

Explore Novel Research Areas with us in our second Session Theme of the day. Connect now to our virtual platform: rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma

Take a break, grab some coffee, and network with fellow attendees. Those at home, visit our virtual platform for exclusive content and session replays: rb.gy/s6p2aw #AMMF2025 #Networking

Join the panel discussion and share your thoughts on the latest AMMF-funded research updates in CCA. Participate in the discussion on our virtual platform: rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma

iCCA and biomarkers are the topic of the next talk with Dr Alicia-Marie Conway. Tune in now to catch this session on our virtual platform: rb.gy/s6p2aw @cruk-mi.bsky.social #AMMF2025 #cholangiocarcinoma

At #AMMF2025, Tamara Mulley shared her experience of Stage 4 CCA at 28. Her goal: “To live as well as possible for as long as possible.” She spoke powerfully about care that listens, values quality of life, and supports patients to keep living and making memories.

Listen to @jenmorton.bsky.social talk about identifying new treatment opportunities for #biliarycancers in the lab. Join the presentation on our virtual platform: rb.gy/s6p2aw @cruk-si.bsky.social #AMMF2025 #cholangiocarcinoma

Dr Ed Jarman will delve into whether retinol from hepatic stellate cells fuel tumour cells during CCA initiation. Join us on our virtual platform: rb.gy/s6p2aw @edinburgh-uni.bsky.social #AMMF2025 #cholangiocarcinoma

Join us at 9:10 am as Tamara Mulley presents the final and powerful patient perspective of the conference. Tune in to our virtual platform rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma

Conclude the day with networking and discussions. See you tomorrow for more insights! Visit our virtual platform for highlights and session replays: rb.gy/s6p2aw #AMMF2025 #cholangiocarcinoma

The second #AMMF Award honours the one and only Mr Hassan Malik. Consultant HPB Surgeon and Clinical Lead at University Hospital Aintree, he’s performed 450+ resections, published 60+ papers, and remains a tireless supporter of AMMF. Thank you for your dedication. @nhsuhlg.bsky.social

The first AMMF Award goes to Andrea Sheardown - a formidable, unstoppable force and tireless ambassador for AMMF. From a gruelling 800km bike ride across India to raising over £150,000, Andrea’s impact is profound. No stopping her - and no sign she’s slowing down. #AMMF2025

"We began advocating for prevention, early detection, and treatment of liver, pancreas and BTC in Africa.” Dr Lewis Roberts @MayoClinic shares the work of the AHPBCC, building clinical, research & advocacy skills across the continent. Conference: Johannesburg, Aug 2025 #AMMF2025